Af­ter rocky hep C path, Achillion finds sur­er foot­ing with FDA break­through sta­tus

Achillion’s promis­ing proof-of-con­cept da­ta for its lat­est drug has won break­through sta­tus at the FDA.

The US reg­u­la­tor grant­ed its cov­et­ed des­ig­na­tion to dan­i­co­pan as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER